BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32383345)

  • 1. Prophylactic oseltamivir during major seasonal influenza H1N1 outbreak might reduce both H1N1 and associated pulmonary aspergillosis in children undergoing haploidentical transplantation.
    Jaiswal SR; Bhagwati G; Soni M; Thatai A; Aiyer H; Chakrabarti S
    Transpl Infect Dis; 2020 Oct; 22(5):e13309. PubMed ID: 32383345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of pandemic influenza H1N1 virus in young patients after oseltamivir therapy in the 2009-2010 season: a comparison with seasonal H1N1 with or without H275Y mutation.
    Kawai N; Ikematsu H; Iwaki N; Kondou K; Hirotsu N; Kawashima T; Maeda T; Tanaka O; Doniwa K; Iwakuni O; Egashira K; Yamaji K; Kashiwagi S
    J Infect Chemother; 2012 Apr; 18(2):180-6. PubMed ID: 22193710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful use of oseltamivir prophylaxis in managing a nosocomial outbreak of influenza A in a hematology and allogeneic stem cell transplant unit.
    Yue MC; Collins JT; Subramoniapillai E; Kennedy GA
    Asia Pac J Clin Oncol; 2017 Feb; 13(1):37-43. PubMed ID: 27730741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oseltamivir resistance in human seasonal influenza viruses (A/H1N1) in EU and EFTA countries: an update.
    Influenza Project Team
    Euro Surveill; 2008 Feb; 13(6):. PubMed ID: 18445425
    [No Abstract]   [Full Text] [Related]  

  • 5. Control of an H1N1 outbreak in a correctional facility in central Taiwan.
    Chao WC; Liu PY; Wu CL
    J Microbiol Immunol Infect; 2017 Apr; 50(2):175-182. PubMed ID: 26051221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Household transmissibility and other characteristics of seasonal oseltamivir-resistant influenza A(H1N1) viruses, Germany, 2007-8.
    Buchholz U; Brockmann S; Duwe S; Schweiger B; an der Heiden M; Reinhardt B; Buda S
    Euro Surveill; 2010 Feb; 15(6):. PubMed ID: 20158979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oseltamivir ring prophylaxis for containment of 2009 H1N1 influenza outbreaks.
    Lee VJ; Yap J; Cook AR; Chen MI; Tay JK; Tan BH; Loh JP; Chew SW; Koh WH; Lin R; Cui L; Lee CW; Sung WK; Wong CW; Hibberd ML; Kang WL; Seet B; Tambyah PA
    N Engl J Med; 2010 Jun; 362(23):2166-74. PubMed ID: 20558367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging oseltamivir resistance in seasonal and pandemic influenza A/H1N1.
    Renaud C; Kuypers J; Englund JA
    J Clin Virol; 2011 Oct; 52(2):70-8. PubMed ID: 21684202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of oseltamivir in children.
    Jamieson B; Jain R; Carleton B; Goldman RD
    Can Fam Physician; 2009 Dec; 55(12):1199-201. PubMed ID: 20008597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus load kinetics and resistance development during oseltamivir treatment in infants and children infected with Influenza A(H1N1) 2009 and Influenza B viruses.
    Rath B; von Kleist M; Tief F; Karsch K; Tuerk E; Muehlhans S; Louis F; Skopnik H; Schweiger B; Duwe S
    Pediatr Infect Dis J; 2012 Sep; 31(9):899-905. PubMed ID: 22581220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza antiviral prescribing practices during the 2007-08 and 2008-09 influenza seasons in the setting of increased resistance to oseltamivir among circulating influenza viruses.
    Dharan NJ; Beekmann SE; Fiore A; Finelli L; Uyeki TM; Polgreen PM; Fry AM
    Antiviral Res; 2010 Nov; 88(2):182-6. PubMed ID: 20739002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010.
    Meijer A; Jonges M; Abbink F; Ang W; van Beek J; Beersma M; Bloembergen P; Boucher C; Claas E; Donker G; van Gageldonk-Lafeber R; Isken L; de Jong A; Kroes A; Leenders S; van der Lubben M; Mascini E; Niesters B; Oosterheert JJ; Osterhaus A; Riesmeijer R; Riezebos-Brilman A; Schutten M; Sebens F; Stelma F; Swaan C; Timen A; van 't Veen A; van der Vries E; te Wierik M; Koopmans M
    Antiviral Res; 2011 Oct; 92(1):81-9. PubMed ID: 21767571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oseltamivir for control of influenza at mass gatherings.
    Tashani M; Rashid H; Ridda I; Heron L; Memish ZA; Haworth E; Booy R
    Infect Disord Drug Targets; 2013 Feb; 13(1):46-52. PubMed ID: 23675926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical characteristics and molecular epidemiology of the novel influenza A (H1N1) infection in children in Shanghai].
    Wang XS; Cai JH; Yao WL; Ge YL; Zhu QR; Zeng M
    Zhonghua Er Ke Za Zhi; 2013 May; 51(5):356-61. PubMed ID: 23941842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of oseltamivir resistance in Sydney, during the Newcastle outbreak of community transmitted oseltamivir-resistant influenza A(H1N1)pdm09 virus, Australia, June to August 2011.
    Wang B; Taylor J; Ratnamohan M; McPhie K; Kesson A; Dixit R; Booy R; Hurt A; Saksena N; Dwyer DE
    Euro Surveill; 2012 Jul; 17(27):. PubMed ID: 22790606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oseltamivir-resistant pandemic (H1N1) 2009 influenza in a severely ill patient: the first Australian case.
    Speers DJ; Williams SH; Pinder M; Moody HR; Hurt AC; Smith DW
    Med J Aust; 2010 Feb; 192(3):166-8. PubMed ID: 20121687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis.
    Baz M; Abed Y; Papenburg J; Bouhy X; Hamelin ME; Boivin G
    N Engl J Med; 2009 Dec; 361(23):2296-7. PubMed ID: 19907034
    [No Abstract]   [Full Text] [Related]  

  • 18. Pandemic (H1N1) 2009 influenza in hospitalized children in Manitoba: nosocomial transmission and lessons learned from the first wave.
    Fanella ST; Pinto MA; Bridger NA; Bullard JM; Coombs JM; Crockett ME; Olekson KL; Poliquin PG; Van Caeseele PG; Embree JE
    Infect Control Hosp Epidemiol; 2011 May; 32(5):435-43. PubMed ID: 21515973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined interventions for mitigation of an influenza A (H1N1) 2009 outbreak in a physical training camp in Beijing, China.
    Chu CY; de Silva UC; Guo JP; Wang Y; Wen L; Lee VJ; Li SL; Huang LY
    Int J Infect Dis; 2017 Jul; 60():77-82. PubMed ID: 28483722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
    Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S
    Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.